MedTrace Logo

Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma

NCT03825302 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-03-17

No results posted yet for this study

Summary

This study seeks to understand how biological sex influences airway hyperresponsiveness in adult asthma.

Conditions

Interventions

DIAGNOSTIC_TEST

Methacholine challenge

Methacholine inhalation challenge will be administered to both male and females with asthma

DIAGNOSTIC_TEST

Mannitol challenge

Mannitol inhalation challenge will be administered to both male and females with asthma

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Katherine Cahill, MD · Vanderbilt University Medical Center

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-12-01
Completion
2022-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03825302 on ClinicalTrials.gov